Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

166 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Time to replace Bazett's QT-correction.
Woosley RL, Romero K. Woosley RL, et al. Pacing Clin Electrophysiol. 2009 Nov;32(11):1379-80. doi: 10.1111/j.1540-8159.2009.02513.x. Epub 2009 Aug 27. Pacing Clin Electrophysiol. 2009. PMID: 19712074 No abstract available.
The Coalition Against Major Diseases: developing tools for an integrated drug development process for Alzheimer's and Parkinson's diseases.
Romero K, de Mars M, Frank D, Anthony M, Neville J, Kirby L, Smith K, Woosley RL. Romero K, et al. Clin Pharmacol Ther. 2009 Oct;86(4):365-7. doi: 10.1038/clpt.2009.165. Clin Pharmacol Ther. 2009. PMID: 19763117
The future is now: model-based clinical trial design for Alzheimer's disease.
Romero K, Ito K, Rogers JA, Polhamus D, Qiu R, Stephenson D, Mohs R, Lalonde R, Sinha V, Wang Y, Brown D, Isaac M, Vamvakas S, Hemmings R, Pani L, Bain LJ, Corrigan B; Alzheimer's Disease Neuroimaging Initiative; Coalition Against Major Diseases. Romero K, et al. Clin Pharmacol Ther. 2015 Mar;97(3):210-4. doi: 10.1002/cpt.16. Epub 2014 Dec 27. Clin Pharmacol Ther. 2015. PMID: 25669145 Free PMC article.
Adverse Drug Event Causality Analysis (ADECA): A Process for Evaluating Evidence and Assigning Drugs to Risk Categories for Sudden Death.
Woosley RL, Romero K, Heise CW, Gallo T, Tate J, Woosley RD, Ward S. Woosley RL, et al. Drug Saf. 2017 Jun;40(6):465-474. doi: 10.1007/s40264-017-0519-0. Drug Saf. 2017. PMID: 28275963 Review.
CredibleMeds.org: What does it offer?
Woosley RL, Black K, Heise CW, Romero K. Woosley RL, et al. Trends Cardiovasc Med. 2018 Feb;28(2):94-99. doi: 10.1016/j.tcm.2017.07.010. Epub 2017 Aug 1. Trends Cardiovasc Med. 2018. PMID: 28801207 Review.
Towards Bridging Translational Gap in Cardiotoxicity Prediction: an Application of Progressive Cardiac Risk Assessment Strategy in TdP Risk Assessment of Moxifloxacin.
Patel N, Hatley O, Berg A, Romero K, Wisniowska B, Hanna D, Hermann D, Polak S. Patel N, et al. AAPS J. 2018 Mar 14;20(3):47. doi: 10.1208/s12248-018-0199-4. AAPS J. 2018. PMID: 29541956
Warfarin interactions with substances listed in drug information compendia and in the FDA-approved label for warfarin sodium.
Anthony M, Romero K, Malone DC, Hines LE, Higgins L, Woosley RL. Anthony M, et al. Clin Pharmacol Ther. 2009 Oct;86(4):425-9. doi: 10.1038/clpt.2009.95. Epub 2009 Jul 8. Clin Pharmacol Ther. 2009. PMID: 19587643
Pharmacometrics as a discipline is entering the "industrialization" phase: standards, automation, knowledge sharing, and training are critical for future success.
Romero K, Corrigan B, Tornoe CW, Gobburu JV, Danhof M, Gillespie WR, Gastonguay MR, Meibohm B, Derendorf H. Romero K, et al. J Clin Pharmacol. 2010 Sep;50(9 Suppl):9S-19S. doi: 10.1177/0091270010377788. J Clin Pharmacol. 2010. PMID: 20881213 No abstract available.
Modeling and simulation for medical product development and evaluation: highlights from the FDA-C-Path-ISOP 2013 workshop.
Romero K, Sinha V, Allerheiligen S, Danhof M, Pinheiro J, Kruhlak N, Wang Y, Wang SJ, Sauer JM, Marier JF, Corrigan B, Rogers J, Lambers Heerspink HJ, Gumbo T, Vis P, Watkins P, Morrison T, Gillespie W, Gordon MF, Stephenson D, Hanna D, Pfister M, Lalonde R, Colatsky T. Romero K, et al. J Pharmacokinet Pharmacodyn. 2014 Dec;41(6):545-52. doi: 10.1007/s10928-014-9390-0. Epub 2014 Oct 7. J Pharmacokinet Pharmacodyn. 2014. PMID: 25288257
Clarification to the www.qtdrugs.org updated lists.
Romero K, Woosley RL. Romero K, et al. Pharmacoepidemiol Drug Saf. 2009 May;18(5):423-4. doi: 10.1002/pds.1727. Pharmacoepidemiol Drug Saf. 2009. PMID: 19382150 No abstract available.
166 results
Jump to page
Feedback